We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+1.99%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
10 Year Est. Return
AUM
$5.31B
AUM Growth
-$186M
Cap. Flow
-$183M
Cap. Flow %
-3.46%
Top 10 Hldgs %
19.09%
Holding
839
New
96
Increased
271
Reduced
217
Closed
105

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$58.6M
2
BIIB icon
Biogen
BIIB
+$40.7M
3
DISCK
Discovery, Inc. Series C Common Stock
DISCK
+$29.8M
4
BIDU icon
Baidu
BIDU
+$27.4M
5
AAPL icon
Apple
AAPL
+$24.6M

Sector Composition

Rank Sector Weight
1 Healthcare 14.94%
2 Industrials 14.89%
3 Financials 13.29%
4 Energy 11.49%
5 Consumer Discretionary 11.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DJP icon
326
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$819M
$710K 0.01%
20,670
-7,025
-25% -$258K
PED icon
327
PEDEVCO
PED
$159M
$706K 0.01%
2,152
+622
+41% +$222K
ENV
328
DELISTED
ENVESTNET, INC.
ENV
$706K 0.01%
15,689
-7,996
-34% -$366K
TAP icon
329
Molson Coors Class B
TAP
$7.68B
$703K 0.01%
+9,438
New +$689K
VO icon
330
Vanguard Mid-Cap ETF
VO
$106B
$700K 0.01%
23,860
+400
+2% +$11.9K
PSA.PRR
331
DELISTED
PUBLIC STORAGE DEPOSITORY SH REPSTG 1/1000TH PFD SER R
PSA.PRR
$699K 0.01%
+27,212
New +$701K
SGNT
332
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
$692K 0.01%
22,261
PX
333
DELISTED
Praxair Inc
PX
$690K 0.01%
5,351
+283
+6% +$37.1K
SPSC icon
334
SPS Commerce
SPSC
$2.25B
$687K 0.01%
25,850
+4,868
+23% +$135K
DDC
335
DELISTED
Dominion Diamond Corporation
DDC
$685K 0.01%
48,125
+11,410
+31% +$159K
HME
336
DELISTED
HOME PROPERTIES, INC
HME
$665K 0.01%
11,425
-5,530
-33% -$349K
AXIA.PR
337
DELISTED
AXIA Energia American Depositary Shares Preferred Class B1
AXIA.PR
$660K 0.01%
158,590
-17,370
-10% -$85.1K
FITB
338
Fifth Third Bancorp
FITB
$52B
$659K 0.01%
32,940
NFX
339
DELISTED
Newfield Exploration
NFX
$659K 0.01%
17,780
+3,760
+27% +$156K
RKUS
340
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$657K 0.01%
49,207
EWM icon
341
iShares MSCI Malaysia ETF
EWM
$305M
$650K 0.01%
10,553
DUK icon
342
Duke Energy
DUK
$102B
$639K 0.01%
8,550
-107
-1% -$7.81K
FISV
343
Fiserv Inc
FISV
$27.2B
$632K 0.01%
19,560
+132
+0.7% +$4.17K
NOV icon
344
NOV
NOV
$7.45B
$628K 0.01%
8,250
+82
+1% +$6.78K
BRK.A icon
345
Berkshire Hathaway Class A
BRK.A
$1.07T
$621K 0.01%
+3
New +$599K
EXAM
346
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
$615K 0.01%
18,788
-1,162
-6% -$38.2K
KALU icon
347
Kaiser Aluminum
KALU
$2.67B
$611K 0.01%
8,020
+3,525
+78% +$272K
PFF icon
348
iShares Preferred and Income Securities ETF
PFF
$13.2B
$605K 0.01%
15,307
MET icon
349
MetLife
MET
$61B
$604K 0.01%
12,612
+116
+0.9% +$5.63K
PBR icon
350
Petrobras
PBR
$121B
$595K 0.01%
41,960
-4,850
-10% -$81.2K

Similar funds

Geneva Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Geneva Advisors held 839 positions worth $5.31B, down 3.4% from $5.49B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneva Advisors withdrew a net $183M in Q3 2014, closing 105 positions and reducing 217 holdings. Its most notable exit was ASPEN TECHNOLOGY INC, an estimated $24.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Industrials and Financials.

Against the trend, Geneva Advisors opened a new position in Discovery, Inc. Series C Common Stock worth $27.5M.

  • Geneva Advisors's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 736,897 shares worth $27.5M.
  • Geneva Advisors added most to AbbVie in Q3 2014, an estimated $58.6M increase.
  • Geneva Advisors's biggest Q3 2014 reduction was Warner Bros, cutting an estimated $62.3M.
  • Geneva Advisors fully exited ASPEN TECHNOLOGY INC in Q3 2014, selling an estimated $24.6M.
  • Geneva Advisors's ten largest holdings make up 19% of its $5.31B portfolio in Q3 2014.
  • Geneva Advisors opened 96 new positions and closed 105 in Q3 2014.
  • Geneva Advisors's portfolio value fell 3.4% quarter-over-quarter to $5.31B.

Based on Geneva Advisors's 13F filing for Q3 2014, filed 3 Nov 2014.